Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.

Peyser A, Machardy N, Tarapore F, Machardy J, Powell L, Gipson DS, Savin V, Pan C, Kump T, Vento S, Trachtman H.

BMC Nephrol. 2010 Jan 29;11:2. doi: 10.1186/1471-2369-11-2.

PMID:
20113498
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Delay in diagnosis in poststreptococcal glomerulonephritis.

Pais PJ, Kump T, Greenbaum LA.

J Pediatr. 2008 Oct;153(4):560-4. doi: 10.1016/j.jpeds.2008.04.021. Epub 2008 May 19.

PMID:
18534213
[PubMed - indexed for MEDLINE]
3.

Obstacles to the prescribing of growth hormone in children with chronic kidney disease.

Greenbaum LA, Hidalgo G, Chand D, Chiang M, Dell K, Kump T, Peschansky L, Smith HK, Boyle M, Kopf M, Metz LC, Kamel M, Mahan JD.

Pediatr Nephrol. 2008 Sep;23(9):1531-5. doi: 10.1007/s00467-008-0857-3. Epub 2008 Jun 5.

PMID:
18528712
[PubMed - indexed for MEDLINE]
4.

Rickets in the Dairy State.

Mylott BM, Kump T, Bolton ML, Greenbaum LA.

WMJ. 2004;103(5):84-7.

PMID:
15553572
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk